Brivaracetam Injection, Solution
Product Images NDC 72205-272

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Brivaracetam (NDC 72205-272). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Novadoz Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Brivaracetam-carton-label (Brivaracetam Carton Label)

Brivaracetam-carton-label (Brivaracetam Carton Label)
Packaging label for Brivaracetam Injection 50 mg/5 mL (10 mg/mL) intravenous solution, supplied as 10 x 5 mL single-dose vials. The label indicates Rx only use and features storage instructions and inactive ingredients. Manufactured by MSN Laboratories Private Limited and distributed by Novadoz Pharmaceuticals LLC.*
FDA Label Image

Brivaracetam-figure-1 (Brivaracetam Figure 1)

Brivaracetam-figure-1 (Brivaracetam Figure 1)
A bar chart illustrating the proportion of patients by percentage in different categories of seizure frequency reduction from baseline. The categories on the x-axis are 'Worse', '0 to <25%', '25 to <50%', '50 to <75%', and '75 to 100%'. The y-axis shows the proportion of patients in percentage. Four groups are compared: Placebo, Brivaracetam 50 mg/day, Brivaracetam 100 mg/day, and Brivaracetam 200 mg/day, each represented by differently shaded bars, indicating varying patient response distributions across the seizure reduction categories.*
FDA Label Image

Brivaracetam-structure (Brivaracetam Structure)

Brivaracetam-structure (Brivaracetam Structure)
Chemical structure of brivaracetam, showing its molecular framework with characteristic amide and lactam groups.*
FDA Label Image

Brivaracetam-vial-label (Brivaracetam Vial Label)

Brivaracetam-vial-label (Brivaracetam Vial Label)
Label for Brivaracetam Injection 50 mg/5 mL (10 mg/mL) single-dose vial for intravenous use. The label includes storage instructions and manufacturer information: produced by MSN Laboratories Private Limited, India, and distributed by Novadoz Pharmaceuticals LLC, Piscataway, NJ. It features a barcode and contact phone number for Novadoz.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.